Professor Fukushima Addresses ‘A Tremendous Crisis’ of Vaccine Related Harm

By NZDSOS September 12, 2023

Professor Masanori Fukushima first reached international attention in November 2022 when he attended an extraordinary session in the House of Representatives in Tokyo to challenge the Japanese Ministry of Health on the harms their interventions were causing. As an oncologist, pharmaco-epidemiologist, clinical trials and regulatory affairs scientist Professor Fukushima joins the growing number of qualified professionals with highly relevant experience who have been sounding the alarm about the dangers of the medical products unleashed onto populations worldwide.

Most recently Professor Fukushima has been named the representative director of the Japanese Society for Vaccine Related Complications (JSVRC), launched with medical, science and legal colleagues associated with various academic and private institutions in Japan. The JSVRC held a one hour press conference at the Ministry of Health on 7 September 2023, which is available here in Japanese. Thanks go to @shortshort_news on Twitter for this two minute English transcript of Professor Fukushima addressing the media. The video and transcript are below.

NZDSOS stand with Professor Fukushima and his colleagues, in denouncing the pharmaceutical products which are causing grave harm to populations, and calling for all physicians and scientists to begin immediately collaborating to address this crisis. This must be done in a way that ensures this can never happen again.

Join NZDSOS on 16 September at our first public conference, to learn more about our work and the collaborations being formed within and beyond New Zealand. In-person attendance is sold out, but online tickets are available here. If you are joining us for the event, we look forward to seeing you there.

https://lionessofjudah.substack.com/p/professor-fukushima-addresses-a-tremendous?utm_source=post-email-title&publication_id=581065&post_id=137028340&utm_campaign=email-post-title&isFreemail=true&r=o554c&utm_medium=email

CA Gov. Bemoans Pandemic Bungling, Blames Others

Sept 14, 2023

Remember 2020…

Nov 14, 2020

In Gov. Gavin Newsom’s new interview with Chuck Todd, the CA Governor bemoans the anger he faced after his much-derided COVID-19 lockdown strategy, now saying “I think we would’ve done everything differently” in hindsight and “I think there’s a lot of humility” – before backtracking and passing the blame to others: “we didn’t know what we didn’t know. And it was hardly I; it was we, collectively.”

John Phillips and Dr. Kelly Victory discuss the new wave of history-rewriting and blame-passing from officials who previously championed lockdowns and mandates but are suddenly changing their tune as election season approaches.

https://rumble.com/v3hel5e-ca-gov.-bemoans-pandemic-bungling-blames-others-w-john-phillips-and-dr.-kel.html

CA Gov. Bemoans Pandemic Bungling, Blames Others w/ John Phillips & Dr. Kelly Victory – Ask Dr. Drew

In Gov. Gavin Newsom’s new interview with Chuck Todd, the CA Governor bemoans the anger he faced after his much-derided COVID-19 lockdown strategy, now saying “I think we would’ve done everything differently” in hindsight and “I think there’s a lot of humility” – before backtracking and passing the blame to others: “we didn’t know what we didn’t know. And it was hardly I; it was we, collectively.” ••「 CALL IN & LINKS: https://drdrew.com/9132023 」•• John Phillips and Dr. Kelly Victory discuss the new wave of history-rewriting and blame-passing from officials who previously championed lockdowns and mandates but are suddenly changing their tune as election season approaches

https://rumble.com/v3hel5e-ca-gov.-bemoans-pandemic-bungling-blames-others-w-john-phillips-and-dr.-kel.html

Povidone Iodine (PVP-I) Oro-Nasal Spray: An Effective Shield for COVID-19 Protection for Health Care Worker (HCW), for all

Published online 4/8/2022

Published PubMed Oct 2022

Benefits of PVP-I Oro-Nasal Spray in Brief

Benefits of 0.6% PVP-I

  • Effective virucidal agent against all coronaviruses, including SARS- COV-2.
  • Effective in case of both pre and post exposure.
  • Effective for healthy individual (for protection) as well as COVID-19 patient also ( for reduction of viral load and SARS-CoV-2 transmissibility for close contacts/ family members).
  • Almost no side effect (mucosal irritation, thyroid dysfunction, teeth staining,).
  • This minimum concentration of PVP-I (0.6%) has least possibility of doing any harm to human body (nasal or oral mucosa). More concentration is being used on eye, ear, mucosa of oral cavity, oropharynx since before.
  • No chance of resistance
  • Reduces disease burden by minimizing sign- symptoms, like-nasal congestion, sore throat.

Benefits of Oro-Nasal Spray

  • Single container, double function (PVP-I Oral/Throat spray as well as Nasal spray)
  • Easy to carry (in pocket, handbag)
  • Easy to use
  • No need to have a basin or a facility to gargle or spit
  • Minimum amount of PVP-I solution is needed (20 ml solution can be used for 20- 30 days for regular user.)
  • Cheap (to refill)
  • Minimum Iodine exposure.
  • Container can be reusable and refillable.

Recommendations

PVP-I Oro Nasal Spray should be used by doctors or other health care workers (HCW), COVID-19 patients as well as common people.

For Doctors or Other Health Care Workers (HCW).

  • Prior to visit any patient in any facility irrespective of COVID status
  • Prior to examining the oral cavity, throat or nose of any patient
  • Prior to any Surgery, specially surgery of Nose, mouth, throat, ear, skull base
  • Prior to attend COVID-19 patient in a COVID-19 dedicated unit / hospital
  • Following exposure to confirmed or suspected COVID patient (intentional/accidental)

For Common People

  • Prior to attend public gathering or working outside home, where there is chance of known or unknown COVID-19 patient/ SARS-CoV-2 exposure.
  • Before leaving and after returning home and in between 1 or 2 time (after tea/lunch/dinner break).
  • For COVID-19 patientsAs it has the potentiality to reduce the viral load, it will definitely reduce the viral transmission from patient to healthy person. Again, it may have positive role on treatment, in mortality and morbidity index. To prove this further studies are recommended.
  • How to use: 2–3 puff in each nostril and 1–3 puff in throat (oral cavity and oropharynx) in 3–4 h interval.
  • How long? Though it is proved and established that long term (1–2 months) application of this minimum amount of PVP-I is quite safe SPS:refid::bib2|bib3|bib4[2,3,4]. But, I recommend after continuous use of 1–2 week 1 day interval (weekly holiday) should be given.

Conclusion

PPE, mask, hand sanitization or vaccines nothing proved 100% effective for COVID-19 prevention still now. PVP-I oro-nasal spray is an easy tool or way for COVID-19 prevention and reduction of SARS-CoV-2 transmissibility. I recommend here, this oro-nasal spray should be used as an adjunct to PPE, mask or vaccine. Any person, policy maker, local or central government could adopt this safe, cheap, easily available and effective PVP-I Oro-Nasal spray as an additional shield of their COVID-19 protection and thus minimize the COVID burden.

https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8026810/

Day 155 of Year 9 Low-SOS Vegan Plan

EXERCISE:
* Climbed many flights of stairs & power walked

WATER: (2) × (32) = 64 oz

EATS:
* tofu-veggie Mongolian bbq stirfry
* commuter crunch (keeps you alert when driving long stretches of stop & go traffic) – carrots, sliced raw almonds, mini rice crackers & vegan buffalo dip
* dairyfree roasted veggie pizza
* sparkling Gerolsteiner spring mineral water w/ shot of soft XL-drink
* grapenut flakes w/ fresh peach, sliced almonds & almond milk

SUN HAS SET

Cmmt: XL indicates uncommon extravagantly luscious food

Biden’s Covid Censorship Struck Down In Court

Sept 13, 2023

Professor of medicine at Stanford University and co-founder of, ‘Illusion of Consensus,’ Substack Dr. Jay Bhattacharya talks about the Missouri v. Biden case. #freespeech #federalcourt

https://www.illusionconsensus.com

According to the CDC, all COVID-19 vaccines currently available in the United States are effective at preventing COVID-19. Getting sick with COVID-19 can offer some protection from future illness, sometimes called “natural immunity,” but the level of protection people get from having COVID-19 may vary depending on how mild or severe their illness was, the time since their infection, and their age. Getting a COVID-19 vaccination is also a safer way to build protection than getting sick with COVID-19. COVID-19 vaccination helps protect you by creating an antibody response without you having to experience sickness. Getting vaccinated yourself may also protect people around you, particularly people at increased risk for severe illness from COVID-19.

Getting sick with COVID-19 can cause severe illness or death, and we can’t reliably predict who will have mild or severe illness. If you get sick, you can spread COVID-19 to others. You can also continue to have long-term health issues after COVID-19 infection. According to the CDC all COVID-19 vaccines currently available in the United States are effective at preventing COVID-19. Getting sick with COVID-19 can offer some protection from future illness, sometimes called “natural immunity,” but the level of protection people get from having COVID-19 may vary depending on how mild or severe their illness was, the time since their infection, and their age. The FDA has not authorized or approved ivermectin for use in preventing or treating COVID-19 in humans or animals. Ivermectin is approved for human use to treat infections caused by some parasitic worms and head lice and skin conditions like rosacea. Currently available data do not show ivermectin is effective against COVID-19. Clinical trials assessing ivermectin tablets for the prevention or treatment of COVID-19 in people are ongoing. Taking large doses of ivermectin is dangerous. If your health care provider writes you an ivermectin prescription, fill it through a legitimate source such as a pharmacy, and take it exactly as prescribed. Never use medications intended for animals on yourself or other people. Animal ivermectin products are very different from those approved for humans. Use of animal ivermectin for the prevention or treatment of COVID-19 in humans is dangerous.

Source: https://www.fda.gov/consumers/consume…

In April 2021, increased cases of myocarditis and pericarditis were reported in the United States after mRNA COVID-19 vaccination (Pfizer-BioNTech and Moderna). Data from multiple studies show a rare risk for myocarditis and/or pericarditis following receipt of mRNA COVID-19 vaccines. These rare cases of myocarditis or pericarditis have occurred most frequently in adolescent and young adult males, ages 16 years and older, within 7 days after receiving the second dose of an mRNA COVID-19 vaccine (Pfizer-BioNTech and Moderna). There has not been a similar reporting pattern observed after receipt of the Janssen COVID-19 Vaccine (Johnson & Johnson). CDC continues to recommend COVID-19 vaccination for everyone 6 months of age and older. The Advisory Committee on Immunization Practices (ACIP) and CDC have determined that the benefits (such as prevention of COVID-19 cases and its severe outcomes) outweigh the risks of myocarditis and pericarditis after receipt of mRNA COVID-19 vaccines.

For more info: 

https://www.cdc.gov/vaccines/covid-19…

According to the CDC, Atrazine is a widely used chlorotriazine herbicide active against broadleaf and grassy weeds. Related chlorotriazine herbicides include simazine, propazine, and cyanazine, all which act by inhibiting plant photosynthesis. Atrazine is applied pre- and post-emergence to agricultural land for crops such as corn and sorghum. It is also used as a non-selective herbicide. Atrazine was first registered as an herbicide in 1958. More than 70 million pounds have been applied annually in recent years, with about 75% of corn cropland receiving treatment. Atrazine has limited water solubility and is not tightly bound to soil, but is leachable in to ground and surface waters. In regions where atrazine is used, it is one of the more commonly detected pesticides in surface and ground waters (USGS, 2007). In soils, atrazine is slowly degraded to dealkylated products, which have half-lives of several months. Bacteria and plants can metabolize atrazine to hydroxyatrazine. Atrazine does not bioaccumulate. It has little toxicity in birds and moderate toxicity in some fish and aquatic invertebrates. Atrazine may alter the sexual development of frogs at environmental levels (Gammon et al., 2005; Hayes et al., 2002; U.S.EPA, 2003a).